Media-OutReach Newswire Potential Impact of Takeda's Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Society Vaccinated people nears 900,000 mark, as health ministry in talks for mRNA technology transfer
Media-OutReach Newswire Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Media-OutReach Newswire Ocumension Therapeutics: Annual Results Announcement For The Year Ended December 31, 2020